SCHEMBL7662066

SCHEMBL7662066

Clc1c(Oc2ccc(Br)cc2)sc2ccccc12

nearest known ligand 0.41

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ LOXL2 Q9Y4K0 1/20 0.41
▸ HDAC1 Q13547 1/20 0.40
▸ HDAC8 Q9BY41 1/20 0.40
▸ HDAC6 Q9UBN7 1/20 0.40
▸ MCL1 Q07820 1/20 0.39
▸ MAPT P10636 5/20 0.39
▸ GAA P10253 2/20 0.39
▸ GPR3 P46089 1/20 0.36
▸ ABCG2 Q9UNQ0 1/20 0.36
▸ OGG1 O15527 1/20 0.36
▸ KDM4E B2RXH2 3/20 0.35
▸ MEN1 O00255 2/20 0.35
▸ NPC1 O15118 2/20 0.35
▸ RAB9A P51151 2/20 0.35
▸ KMT2A Q03164 2/20 0.35
▸ PTGS1 P23219 1/20 0.35
▸ PTGS2 P35354 1/20 0.35
▸ F10 P00742 1/20 0.35
▸ PRSS12 P56730 1/20 0.33
▸ CD274 Q9NZQ7 1/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7670984 0.87 LOXL2 (0.43) LOXL2HDAC1HDAC8HDAC6MCL1
SCHEMBL7662062 0.84 MAPT (0.55) LOXL2MCL1MAPTGAAKDM4E
SCHEMBL7659816 0.84 ESR1 (0.44) LOXL2HDAC1HDAC8HDAC6MCL1
SCHEMBL7879489 0.74 TDP1 (0.44) LOXL2MCL1MAPTGAAKDM4E
SCHEMBL7667320 0.73 LOXL2 (0.43) LOXL2HDAC1HDAC8HDAC6MCL1
SCHEMBL7661911 0.72 LOXL2 (0.42) LOXL2HDAC1HDAC8HDAC6MCL1
SCHEMBL7673205 0.70 KDM4E (0.44) LOXL2MCL1MAPTGAAKDM4E
SCHEMBL28378900 0.69 LOXL2 (0.53) LOXL2HDAC1HDAC8HDAC6MCL1
SCHEMBL7674113 0.69 ALOX5 (0.41) LOXL2HDAC1HDAC8HDAC6MCL1
SCHEMBL7662088 0.69 L3MBTL1 (0.40) LOXL2HDAC1HDAC8HDAC6MCL1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-6458813-B1 2-CYCLOHEXYLOXY-5-(2-CHLOROPHENYLCARBONYLAMINO)PYRIDINE, FOR EXAMPLE; TREATING INFLAMMATION, PAIN, DIABETES, CANCER AMGEN INC. 2002-10-01 — — US disclosed
US-6333341-B1 TUMOR NECROSIS FACTOR, ANTIINFLAMMATORY AGENTS AND ANALGESICS AMGEN INC. 2001-12-25 — — US disclosed
US-6184237-B1 Substituted pyridine compounds and methods of use AMGEN INC. 2001-02-06 — — US disclosed
Send feedback